ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000787.1|O-antigen_1 # 1 # 894 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.511	BGC0000787.1|O-antigen_1 	1	894	+	Loose	500	26.1794	amrA	43.9	3002982	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACGAATTTAAAAGCAGTTATACCGGTAGCAGGTCTTGGGATGCATATGTTGCCTGCCACTAAGGCGATTCCCAAAGAGATGCTACCGATCGTCGACAAGCCAATGATTCAGTACATTGTTGACGAGATTGTGGCTGCAGGGATCAAAGAAATCCTCCTGGTAACTCACGCGTCCAAGAACGCAGTCGAAAACCACTTCGACACCTCTTATGAATTAGAATCTCTCCTTGAACAGCGCGTGAAGCGTCAACTACTGGCGGAAGTACAATCTATCTGTCCGCCGGGCGTGACCATTATGAACGTGCGTCAGGGTGAACCTTTAGGTTTAGGCCACTCCATTTTATGTGCGCGACCTGCCATTGGTGACAATCCATTTGTCGTGGTGCTGCCAGACGTTGTGATCGACGACGCCAGCGCCGACCCGCTACGCTACAACCTTGCTGCCATGATTGCGCGCTTCAATGAAACGGGACGCAGCCAGGTGCTGGCAAAACGTATGCCGGGCGACCTCTCTGAATACTCCGTCATCCAGACCAAAGAACCGCTGGATCGTGAAGGCAAAGTCAGCCGCATTGTTGAATTTATCGAAAAGCCGGATCAGCCGCAGACGCTGGACTCAGACATCATGGCCGTTGGTCGATATGTGCTTTCTGCCGATATTTGGCCGGAACTTGAACGTACTCAGCCTGGTGCATGGGGACGTATTCAGCTGACTGATGCCATTGCCGAGCTGGCGAAAAAACAGTCCGTTGATGCCATGCTGATGACCGGCGACAGCTACGACTGCGGTAAAAAAATGGGTTATATGCAGGCGTTTGTGAAGTATGGACTACGCAACCTGAAAGAAGGGGCGAAGTTCCGTAAAGGGATTGAGAAGCTGTTAAGCGAATAA	MTNLKAVIPVAGLGMHMLPATKAIPKEMLPIVDKPMIQYIVDEIVAAGIKEILLVTHASKNAVENHFDTSYELESLLEQRVKRQLLAEVQSICPPGVTIMNVRQGEPLGLGHSILCARPAIGDNPFVVVLPDVVIDDASADPLRYNLAAMIARFNETGRSQVLAKRMPGDLSEYSVIQTKEPLDREGKVSRIVEFIEKPDQPQTLDSDIMAVGRYVLSADIWPELERTQPGAWGRIQLTDAIAELAKKQSVDAMLMTGDSYDCGKKMGYMQAFVKYGLRNLKEGAKFRKGIEKLLSE	MKYEWARTRRLSAALAVAAFVAAGCGKHESEHDAAAPREASVVTVKKTSVPLSVELPGRLDAYRQAEVRARVAGIVTARTYEEGQEVKRGAVLFRIDPAPFKAARDAAAGALEKARAAHLAALDKRRRYDELVRDRAVSERDHTEALADERQAKAAVASARAELARAQLQLDYATVTAPIDGRARRALVTEGALVGQDQATPLTTVEQLDPIYVNFSQPAADVESLRRAVKSGRAAGIAQQDVEVTLVRPDGSTYARKGKLLFADLAVDPSTDTVAMRALFPNPERELLPGAYVRIALDRAVARDAILVPRDALLRTADSATVKVVGQNGKIRDVTVEAAQMKGRDWIVTRGLAGGERVVVVDAAQFEAGTTVKALERGAAAQPASGAAAASAPGRRST	74.44	gnl|BL_ORD_ID|1419|hsp_num:0	1542			837	960	
BGC0000787.1|O-antigen_2 # 1204 # 2223 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.330	BGC0000787.1|O-antigen_2 	1204	2223	+	Loose	1200	35.4242	arnA	23.57	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGGTGATTTTCGTAACAGGCGGTGCAGGATATATTGGATCCCATACCATACTTGAGTTACTTAATAATGGTCATGATGTCGTTTCGATAGATAATTTTGTCAATTCCTCTATAGAATCATTAAAAAGAGTAGAGCAAATAACTAATAAGAAAATTATTTCTTATCAAGGTGATATCCGTGATAAAAATCTACTTGATGAGATTTTTTCAAGACACCATATCGATGCTGTAATTCACTTTGCATCGTTAAAATCTGTAGGTGAGTCTAAGTTAAAGCCCTTAGAGTATTATTCTAATAATGTTGGTGGAACTTTAGTATTACTTGAATGCATGAAGAGATATAACATTAATAAAATGATATTTAGCTCTTCTGCTACTGTTTATGGGAATAACAGTATCCCTCCCCATACGGAAGATAGACGAATTGGTGAAACTACAAACCCATATGGGACATCGAAATTTATAATAGAAATAATTTTGAGTGATTATTGTGATAGTGATAATAATAAATCAGTAATTGCACTGCGTTACTTTAATCCAATCGGAGCACATAAGTCCGGGATGATTGGTGAAAATCCTAACGGGATTCCTAATAATCTGGTTCCTTATATATCTAAAGTTGCACAAAATCAACTTCCTGTATTAAATATTTATGGCAACGATTATCCAACTAAAGATGGTACAGGAGTAAGAGACTATATACATGTCTGTGATTTGGCTAAAGGGCATGTTAAAGCATTAGAATATATGTTTTTAAATGATGTCAATTATGAAGCTTTTAATTTAGGCACTGGTCAAGGTTATTCTGTTTTAGAGATTGTAAAAATGTTTGAGATAGTCACTAAAAAGAGTATACCTGTTGCTATTTGTAATAGACGTGAGGGGGATGTTGCGGAGTCATGGGCGTCTGCTGATTTAGCACATAAAAAGCTTTCCTGGAAAGCGGAAAAAAAATTGAAAGAAATGATCGAAGATGTATGGCGTTGGCAAACAAACAATCCAAATGGATATAAAAAATAA	MVIFVTGGAGYIGSHTILELLNNGHDVVSIDNFVNSSIESLKRVEQITNKKIISYQGDIRDKNLLDEIFSRHHIDAVIHFASLKSVGESKLKPLEYYSNNVGGTLVLLECMKRYNINKMIFSSSATVYGNNSIPPHTEDRRIGETTNPYGTSKFIIEIILSDYCDSDNNKSVIALRYFNPIGAHKSGMIGENPNGIPNNLVPYISKVAQNQLPVLNIYGNDYPTKDGTGVRDYIHVCDLAKGHVKALEYMFLNDVNYEAFNLGTGQGYSVLEIVKMFEIVTKKSIPVAICNRREGDVAESWASADLAHKKLSWKAEKKLKEMIEDVWRWQTNNPNGYKK	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	51.21	gnl|BL_ORD_ID|1513|hsp_num:0	1643			957	1350	polymyxin B
BGC0000787.1|O-antigen_3 # 2242 # 3258 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.343	BGC0000787.1|O-antigen_3 	2242	3258	+	Loose	700	31.5722	LpsB	25.76	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	ATGAAAAATGTTGGTTTTATTGTTACAAAATCAGAAATTGGTGGTGCACAAACATGGGTAAATGAAATATCTAACCTTATTAAAGAGGAATGTAATATATTTCTTATTACATCTGAAGAAGGATGGCTCACACATAAAGATGTCTTTGCCGGAGTTTTTGTCATACCAGGTATTAAAAAATATTTTGACTTCCTTACATTGTTTAAATTGAGAAAAATTTTAAAAGAAAATAACATTTCAACGTTAATAGCAAGTTCTGCTAATGCCGGAGTTTATGCCAGGTTAGTTCGATTACTAGTCGACTTTAAATGTATTTATGTTTCGCATGGATGGTCTTGTTTATATAATGGTGGTCGCCTAAAATCAATTTTTTGCATTGTGGAAAAATACCTTTCTTTATTAACTGATGTTATATGGTGTGTTTCCAAAAGTGATGAAAAAAAGGCAATTGAGAATATTGGTATAAAAGAACCAAAGATAATCACAGTATCGAATTCAGTGCCTCAGATGCCGAGATGTAATAATAAACAACTCCAGTATAAGGTTCTGTTTGTTGGTAGGTTAACACACCCTAAGCGCCCCGAGTTGTTAGCGAATGTAATATCGAAAAAGCCCCAGTATAGCCTCCATATCGTAGGAGGGGGGGAAAGGTTAGAATCATTGAAGAAACAATTCAGTGAATGTGAAAATATTCATTTTTTGGGTGAGGTCAATAATTTTTATAACTATCATGAGTATGATTTATTTTCACTGATATCCGATAGTGAAGGTTTGCCTATGTCAGGCCTTGAGGCTCACACAGCTGCAATACCACTCCTGTTAAGTGATGTGGGCGGATGTTTTGAATTAATTGAGGGTAATGGGTTACTTGTGGAAAATACTGAAGACGACATTGGATATAAATTGGATAAAATATTCGATGACTATGAAAATTATCGGGAACAGGCAATTCGTGCTTCCGGGAAATTTGTTATCGAGAACTATGCTTCAGCATATAAAAGCATTATTTTAGGTTGA	MKNVGFIVTKSEIGGAQTWVNEISNLIKEECNIFLITSEEGWLTHKDVFAGVFVIPGIKKYFDFLTLFKLRKILKENNISTLIASSANAGVYARLVRLLVDFKCIYVSHGWSCLYNGGRLKSIFCIVEKYLSLLTDVIWCVSKSDEKKAIENIGIKEPKIITVSNSVPQMPRCNNKQLQYKVLFVGRLTHPKRPELLANVISKKPQYSLHIVGGGERLESLKKQFSECENIHFLGEVNNFYNYHEYDLFSLISDSEGLPMSGLEAHTAAIPLLLSDVGGCFELIEGNGLLVENTEDDIGYKLDKIFDDYENYREQAIRASGKFVIENYASAYKSIILG	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	92.35	gnl|BL_ORD_ID|2781|hsp_num:0	3793			558	933	colistin A; colistin B; defensin
BGC0000787.1|O-antigen_4 # 3285 # 4406 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.528	BGC0000787.1|O-antigen_4 	3285	4406	+	Loose	1200	41.5874	arnA	28.26	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGGCTAAAGTCGCTCTCATTACTGGCATAACCGGACAAGACGGTTCTTACCTGGCAGAGTTTCTGCTGGAAAAAGGTTACGAGGTGCATGGTATTAAGCGTCGTGCATCGTCATTCAACACCGAGCGCGTGGATCACATTTATCAGGATCCGCACACCTGCAACCCGAAATTCCATCTGCATTATGGCGATCTGACAGATACCTCCAACCTGACGCGCATTTTGTGTGAAGTGCAGCCGGATGAAGTGTACAACCTGGGCGCAATGAGTCACGTTGCGGTTTCTTTTGAGTCACCGGAATATATCGCTGACGTCGATGCGATGGGTACGCTGCGCCTGCTGGAGGCGATCCGCTTCCTCGGTCTGGAAAAGAAAACCCGTTTTTATCAGGCTTCCACCTCTGAACTGTACGGTCTGGTGCAGGAAATTCCGCAGAAAGAAACCACGCCGTTCTACCCACGCTCTCCGTATGCGGTCGCCAAACTGTATGCCTACTGGATCACCGTTAACTACCGCGAATCCTACGGCATGTACGCCTGTAACGGTATTCTCTTCAACCATGAATCCCCGCGCCGCGGCGAAACCTTCGTTACCCGCAAAATCACCCGCGCAATCGCAAACATCGCCCAGGGGCTGGAATCGTGCCTGTACCTCGGCAATATGGATTCCCTGCGTGACTGGGGCCATGCCAAAGACTACGTAAAAATGCAGTGGATGATGCTGCAACAGGAACAGCCGGAAGATTTCGTTATCGCGACCGGCGTTCAGTACTCCGTGCGTCAGTTCGTGGAAATGGCGGCGGAGCGAGTCGGAATCAAACTGCGTTTTGAAGGCACAGGTGTAGATGAGAAGGGGATAGTGGTTTCTGTTAATGGTGAGGATGCTCCAGCAGTTAAACCTGGAGATGTAATCGTTAAGGTTGATCCGCGCTACTTCCGTCCGGCTGAAGTTGAAACGCTGCTCGGCGNACCGACCAAAGCGCACGAAAAACTGGGCTGGAAACCAGAAATCACCCTCAGAGAGATGGTGTCTGAAATGGTGGCTAATGACCTCGAAGCGGCGAAAAAACACTCTCTGCTGAAATCTCACGGCTACGACGTGGCGATCGCGCTGGAGTCATAA	MAKVALITGITGQDGSYLAEFLLEKGYEVHGIKRRASSFNTERVDHIYQDPHTCNPKFHLHYGDLTDTSNLTRILCEVQPDEVYNLGAMSHVAVSFESPEYIADVDAMGTLRLLEAIRFLGLEKKTRFYQASTSELYGLVQEIPQKETTPFYPRSPYAVAKLYAYWITVNYRESYGMYACNGILFNHESPRRGETFVTRKITRAIANIAQGLESCLYLGNMDSLRDWGHAKDYVKMQWMMLQQEQPEDFVIATGVQYSVRQFVEMAAERVGIKLRFEGTGVDEKGIVVSVNGEDAPAVKPGDVIVKVDPRYFRPAEVETLLGXPTKAHEKLGWKPEITLREMVSEMVANDLEAAKKHSLLKSHGYDVAIALES	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	56.34	gnl|BL_ORD_ID|1513|hsp_num:0	1643			960	1329	polymyxin B
BGC0000787.1|O-antigen_5 # 4409 # 5266 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.556	BGC0000787.1|O-antigen_5 	4409	5266	+	Loose	1900	28.8758	mexQ	38.64	3003699	protein homolog model	n/a	n/a	macrolide antibiotic; carbapenem; tetracycline antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGTAGACAACGCATTTTTATCGCTGGCCATCGCGGAATGGTCGGTTCTGCCATCAGGCGGCAGCTCGAACAGCGCGGTGATGTGGAACTGGTATTACGCACCCGCGACGAGCTGAACCTGCTGGACAGCCGCGCGGTGCATGATTTCTTTGCCAGCGAACGCATTGACCAGGTCTATCTGGCGGCGGCGAAAGTGGGCGGCATTGTTGCCAACAACACCTATCCGGCGGATTTCATCTACCAGAACATGATGATTGAGAGCAACATCATTCACGCCGCGTATCAGAACGACGTGAACAAACTGCTGTTTCTTGGATCGTCCTGTATCTACCCGAAACTGGCAAAACAGCCGATGGCAGAAAGCGAGCTGTTGAAGGGCACGCTGGAGCCGACTAACGAGCCTTATGCTATTGCCAAAATCGCCGGGATCAAACTGTGCGAATCTTACAATCGCCAGTACGGACGCGATTACCGCTCAGTCATGCCGACCAACCTGTACGGGTCGCACGACAACTTCCACCCGAGTAACTCCCATGTGATACCTGCATTGCTGCGTCGCTTCCACGAGGCGACGGCACAGAATGTACCGGACGTGGTGGTGTGGGGCAGCGGTACACCTATGCGCGAATTTCTGCACGTCGATGATATGGCGGCGGCGAGCATTCATGTCATGGAGCTGGCGCATGAAGTCTGGCTGGAGAACACCCAGCCGATGTTGTCGCACATTAACGTCGGCACGGGCGTTGACTGCACTATCCGCGAGCTGGCGCAAATCATCGCCAAAGTGGTGGGTTACAAAGGTCGGGTGGTTTTTGATGCCAGCAAACCGGATGGTACGCCGCAGCAAACTGCTTGA	MSRQRIFIAGHRGMVGSAIRRQLEQRGDVELVLRTRDELNLLDSRAVHDFFASERIDQVYLAAAKVGGIVANNTYPADFIYQNMMIESNIIHAAYQNDVNKLLFLGSSCIYPKLAKQPMAESELLKGTLEPTNEPYAIAKIAGIKLCESYNRQYGRDYRSVMPTNLYGSHDNFHPSNSHVIPALLRRFHEATAQNVPDVVVWGSGTPMREFLHVDDMAAASIHVMELAHEVWLENTQPMLSHINVGTGVDCTIRELAQIIAKVVGYKGRVVFDASKPDGTPQQTA	MTFPRFFIDRPIFAIVLSVLMMIGGIVSFFQLPLSEYPAVTPPTVQVTTAYPGANPDVIAQTVATPLEQAITGVEGMLYMSSQSATDGRMILTITFDQHIDPDMAQIQVQNRVSRVLSRLPDEVQRQGVVTQKTSPDILMVVHLLSPEQRYDPLYISNYAYLQVRDELLRLPGISDVVVWGAGEYSMRLWLDPDLIAARGLTAGEVIAAVREQNVQVAAGAVGQAPDSTAAFQVTVNTLGRLSDEEQFGDIIVRTGADGQVTRLRDVARIEMGGDAYALRSLLDGEPAVALQIIQSPGANALDTAEAVRATVARLEGNFPAGLSARIAYDPTVFVRASLQTVATTLLEAILLVVVVVVLFLRSWRASLIPLMAVPVSLVGTFAVMHLMGFSLNTLSLFGLVLSIGIVVDDAIVVVENVERHIENGEPPLQAARRAMDEVTGPIMAITSVLAAVFIPTAFLSGLQGEFYRQFALTIAISTILSALNSLTLSPALAGLLLRPRPAGGAVAGRFQRLLQVLGRPLRNAPEAYGNAVRKVVRVSGLALVVYGGLLGLTWVGFQAVPPGFVPMQDKYYLIGIAQLPNGASLERTDAVVRQMSRIGLDEPGVESVVAFPGLSVNGFVNVPNAAVMFFMLDPFESRTSADLGALAIAGRLQARFASIPDGFLGVFPPPPVPGLGTIGGFKMQVEDRGGAGLEALARQTQVLMMKATESGQLGGLMTSFDINAPQLEVVVDRTKVKSQGVRLADVFEALQVYLGSLYINDFNRFGRTYKVTAQADAPHRMQAEAIGRLQVRNAAGAMLPLSSFVTVTPSSGPDRVIHYNGYPSADISGGALPGVSSGQAVALMERLAGEVLPEGMTFEWTDLTYQQKLAGNSALFIFPLCVLLAYLILAAQYNSWLLPLAVLLIVPMCLLSAIAGVWLVGGDNNVFVQIGLVVLVGLAAKNAILIVEFARTLEAEGARALEAVVEACRLRLRPILMTSLAFIAGVVPLVMASGAGAEMRQAMGVAVFAGMLGVTLFGLFLTPVFYVLVRALAARLERRAGGSLAHLEGGRP	27.07	gnl|BL_ORD_ID|2010|hsp_num:0	2212			516	648	erythromycin; acriflavine; tetracycline; imipenem; trimethoprim; chloramphenicol; thiamphenicol; kitasamycin; rokitamycin
BGC0000787.1|O-antigen_6 # 5382 # 5882 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.525	BGC0000787.1|O-antigen_6 	5382	5882	+	Loose	500	25.409	OXA-13	37.14	3001408	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGTTTTTACGTCAGGAAGACTTTGCCACGGTAGTGCACTCCACCCCGCTTGTCTCTCTCGACTTTATTGTCGAGAACAGTCGCGGCGAGTTTCTGCTTGGCAAAAGAACCAACCGCCCGGCGCAGGGTTACTGGTTTGTGCCGGGAGGGCGCGTGCAGAAAGACGAAACGCTGGAAGCCGCATTTGAGCGGCTGACGATGGCGGAACTGGGGCTGCGTCTGCCGATAACAGCAGGCCAGTTTTACGGTGTCTGGCAGCACTTTTATGACGATAACTTCTCCGGCACGGATTTCACCACTCACTATGTGGTGCTCGGTTTTCGCTTCAGAGTAGCGGAAGAAGAGCTGTTACTGCCGGATGAGCAGCATGACGATTACCGCTGGCTGACGCCGGACGCGCTGCTCGCCAGTAACAATGTTCACGCTAACAGCCGAGCTTATTTTAATCATGATCCAAGTGCTGTTATTGGTTTAGATAAAAAGGATGTCAAAAATGTCTGA	MFLRQEDFATVVHSTPLVSLDFIVENSRGEFLLGKRTNRPAQGYWFVPGGRVQKDETLEAAFERLTMAELGLRLPITAGQFYGVWQHFYDDNFSGTDFTTHYVVLGFRFRVAEEELLLPDEQHDDYRWLTPDALLASNNVHANSRAYFNHDPSAVIGLDKKDVKNV	MKTFAAYVITACLSSTALASSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNNLARASKEYLPASTFKIPSAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLSLRGAIQVSAVPVFQQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLFLNKLSASKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGTEVYFFAFNMDIDNENKLPLRKSIPTKIMASEGIIGG	62.41	gnl|BL_ORD_ID|416|hsp_num:0	461			150	255	cloxacillin; oxacillin; cefalotin
BGC0000787.1|O-antigen_7 # 5875 # 7323 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.362	BGC0000787.1|O-antigen_7 	5875	7323	+	Loose	1500	26.1794	rphB	22.17	3003992	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	ATGTCTGATGTACCGTTGATTGCTGTTGTAATGGCTGGTGGTACGGGTAGCCGTCTTTGGCCCCTCTCAAGAGAGCACTATCCGAAGCAATTTCTGCAATTATCAGGTGAGAATACTTTATTACAGTCAACTTTATTACGACTATCCCCGCTTTCTTGCGAAACTCCATTAGTAATAACTAACGAGCAGCATCGTTTTGTGGTCGCAGAACAATTGCGTCAAATAAACCAATTAAGCGATAACATTATTCTTGAACCATGTGGAAGAAATACTGCACCAGCTATAGCACTTTCAGCATTTACAGCCTTAAAGCGTAATGAACAACAAGATCCTATACTTTTAGTTCTTGCAGCTGACCATGTTATAAACAAAACAGATGTTTTTTGTAATGCTATTAAAAATTCCATTTCAATTGTTGAACAAGGAAATATTTTAACATTTGGTATTATTCCTGATTATGCAGAAACTGGTTACGGTTATATAGAAAAAGGGAGTATAGTTAAAGAATCACAACGTGGAGTTGGTAATACATTCTATCACGTGGAACAATTTGTTGAAAAACCTAATCGCTCAAGGGCTGAAGAGTATATCTCCTCAGGTAAATATCTCTGGAATAGTGGGATGTTTATGTTCAAAGCATCAGTATATTTAGAGGAGTTAAAAAAATACAGACCTGATATATACGATATATGTGAAAAAACAGTTTCTTCGTCCTACCATGATCTTGATTTTATACGACTTTCGAAAGATGTTTTTCAAAATTGTCCATCGGAATCAATTGATTTTGCAGTAATGGAAAAAACAAAGCGTTGTATAGTCTATCCCGTTGATATTGGTTGGAACGATGTTGGATCTTGGCAATCATTGTGGGACGTTAGTGATAAAACTCCTACAGGGGACGTTTGCAAAGGTGATATCCTGACTTATAATACAAAAAATAATTATATTCATTCGGAGTCAGCCTTAGTAGCCGCTGTAGGTGTGGAGGATATTGTTATTGTTCAGACGAAAGATGCAATTCTAGTTTCAAAAAAATCCGAAGTTCAGGATGTTAAGAAAATTGTTCAAATGCTTAAAATGCAAGAACGTTCTGAATATCTATCACATCGCGAGGAATTTCGTCCTTGGGGAAAGTTTGATGCTATAGAACAGGGAGATCGATATAAGGTCAAAAAGATTGTCGTTAAACCAGGGGAAGGGCTATCCTTACGTATGCATCATCATCGTTCAGAGCATTGGATTGTCCTTTCAGGTACAGCAAAAGTAACGTTAAATAATAAAACTTTCTTAGTTACTGCTAATGAATCCGTTTATATTCCTCTGGGTGCTACTTATAGCCTTGAAAATCCAGGTGTAATTCCTCTCAATCTTATTGAAGTTAGTTCAGGAGATTATTTAGGTGAGGATGATATTGTTCGTCAAAAAGAACGTTACAAAATAGATGACTAA	MSDVPLIAVVMAGGTGSRLWPLSREHYPKQFLQLSGENTLLQSTLLRLSPLSCETPLVITNEQHRFVVAEQLRQINQLSDNIILEPCGRNTAPAIALSAFTALKRNEQQDPILLVLAADHVINKTDVFCNAIKNSISIVEQGNILTFGIIPDYAETGYGYIEKGSIVKESQRGVGNTFYHVEQFVEKPNRSRAEEYISSGKYLWNSGMFMFKASVYLEELKKYRPDIYDICEKTVSSSYHDLDFIRLSKDVFQNCPSESIDFAVMEKTKRCIVYPVDIGWNDVGSWQSLWDVSDKTPTGDVCKGDILTYNTKNNYIHSESALVAAVGVEDIVIVQTKDAILVSKKSEVQDVKKIVQMLKMQERSEYLSHREEFRPWGKFDAIEQGDRYKVKKIVVKPGEGLSLRMHHHRSEHWIVLSGTAKVTLNNKTFLVTANESVYIPLGATYSLENPGVIPLNLIEVSSGDYLGEDDIVRQKERYKIDD	MRSLVLDFQEMDKKQLGLVGGKGLHLGELSKIEGIRVPEGFCVTTIGYQRAIEQNETYQAMLNRLTMLSAEDRDQMVEISRKIRQTIMEVEIPSDVVTAVTRYLSRFGEEQAYAVRSSATAEDLPHASFAGQQDTYLNIIGVDAILQHISKCWASLFTDRAVIYRMQNGFDHRQVYLSVVVQRMVFPEASGILFTADPMTSNRKLLSIDAGFGLGEALVSGLVSADGYKVREGEIIEKRIAAKTLAIYGRKEGGTETKQIDPDQQKSQTLTDEQILQLARIGRQIEAHFGQPQDIEWCLAQDTFYIVQSRPITTLYPIPEANDQENHVYVSVGHQQMMTDPMKPLGLSFFLLTTPAPMRTAGGRLFVDTTAMLASPVSRENVLNTLGQSDPLIKDALMTILERGDFIKSLPIAENEQTPGKNNISSAGYQTPIDHDPTIVSDLMERTQSSIEVLKQNIQTKSGSDLFDFILEDIQELKKNLFDPQSSAVIMAAMNASTWINEKMNEWLGEKNAADTLSQSVPGNVTSEMGLALLDVADVIRPYPEIIDYLEQAKDDHFLDKLLTFDGGQQAQDAILDFLDKYGMRCAGEIDLTRTRWSEKPIALVPLILGNIKNFEPNASHRKFEQGRQEALKKEQELLDRLKQLPDGEGKAQETKRMIDLIRNFMGYREYPKYGMVNRYFIYKQALLKEAERLVQAGVIHHKEDIYYLTFEELDEVVRTNKLDNPGSMVEQQAKLAIRQMISKRKEEYNVFEKLTPPRVITSDGEIIAGEYKRENIPAEAIVGLPVSSGTVEGRARVILNMKDADLEEGDILVTAFTDPSWTPLFVSIKGLVTEVGGLMTHGAVIAREYGLPAVVGVENATKRIKDGQRIRVHGSEGYIEILS	54.52	gnl|BL_ORD_ID|2235|hsp_num:0	2528			1989	2580	rifampin; rifaximin; rifabutin; rifapentine
BGC0000787.1|O-antigen_8 # 7327 # 8700 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.528	BGC0000787.1|O-antigen_8 	7327	8700	+	Loose	2000	25.7942	adeB	27.45	3000775	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAAAAATTAACCTGCTTTAAAGCCTACGATATTCGCGGAAAATTAGGCGAAGAACTGAATGAAGATATTGCCTGGCGTATTGGGCGTGCCTATGGCGAATTTCTCAAACCGAAAACTATTGTTTTAGGTGGTGATGTCCGCCTCACCAGCGAAACCTTAAAACTGGCGCTGGCGAAAGGTTTACAGGATGCGGGCGTCGATGTGCTGGATATCGGCATGTCCGGCACCGAAGAGATCTATTTCGCTACGTTCCATCTCGGCGTGGATGGCGGCATCGAAGTTACTGCCAGCCATAACCCGATGGATTACAACGGCATGAAGCTGGTGCGCGAGGGGGCTCGCCCGATCAGCGGTGATACCGGACTGCGCGATGTCCAGCGTCTGGCAGAAGCCAACGACTTCCCTCCCGTCGATGAAACCAAACGCGGTCGCTATCAGCAAATCAATCTGCGTGAAGCTTACGTTGATCACCTGTTCGGTTATATCAACGTCAAAAACCTCACGCCGCTCAAGCTGGTGATTAACTCCGGGAACGGCGCGGCGGGTCCGGTGGTGGACGCCATTGAAGCCCGCTTTAAAGCCCTCCGCGCACCGGTGGAGTTAATCCAAGTGCATAACACGCCGGACGGCAATTTCCCCAACGGTATTCCTAACCCGCTACTGCCGGAATGTCGCGACGACACCCGCAATGCGGTCATTAAACACGGCGCGGATATGGGCATTGCTTTTGATGGCGATTTTGACCGCTGTTTCCTGTTTGACGAAAAAGGGCAGTTTATTGAGGGTTACTACATTGTCGGTTTGCTGGCAGAGGCGTTCCTCGAAAAAAATCCCGGCGCGAAGATCATCCACGATCCACGTCTCTCCTGGAACACCGTTGATGTGGTGACTGCCGCAGGCGGTACGCCAATAATGTCGAAAACCGGACACGCCTTTATTAAAGAACGTATGCGTAAGGAAGACGCTATCTACGGTGGCGAAATGAGCGCCCACCATTACTTCCGTGATTTCGCTTACTGCGACAGCGGCATGATCCCGTGGCTGCTGGTCGCCGAACTGGTGTGCCTGAAAGGGAAAACGCTGGGCGAACTGGTGCGCGACCGGATGGCGGCTTTTCCGGCAAGTGGTGAGATCAACAGCAAACTCACGCACCCCGTTGAGGCGATTAACCGCGTGGAACAGCATTTTAGCCGTGAGGCGCTGGCGGTGGATCGCACCGATGGCATCAGTATGGCCTTTGCCAACTGGCGCTTTAACCTGCGCTCCTCCAACACCGAACCTGTTGTGCGTTTGAACGTTGAATCAAGAGGTGATCAGCTCGTGATGGAAAATAATACGGCAATTATTATTAATTTATTAAAAGAAAAATAA	MKKLTCFKAYDIRGKLGEELNEDIAWRIGRAYGEFLKPKTIVLGGDVRLTSETLKLALAKGLQDAGVDVLDIGMSGTEEIYFATFHLGVDGGIEVTASHNPMDYNGMKLVREGARPISGDTGLRDVQRLAEANDFPPVDETKRGRYQQINLREAYVDHLFGYINVKNLTPLKLVINSGNGAAGPVVDAIEARFKALRAPVELIQVHNTPDGNFPNGIPNPLLPECRDDTRNAVIKHGADMGIAFDGDFDRCFLFDEKGQFIEGYYIVGLLAEAFLEKNPGAKIIHDPRLSWNTVDVVTAAGGTPIMSKTGHAFIKERMRKEDAIYGGEMSAHHYFRDFAYCDSGMIPWLLVAELVCLKGKTLGELVRDRMAAFPASGEINSKLTHPVEAINRVEQHFSREALAVDRTDGISMAFANWRFNLRSSNTEPVVRLNVESRGDQLVMENNTAIIINLLKEK	MSQFFIRRPVFAWVIAIFIIIFGLLSIPKLPIARFPSVAPPQVNISATYPGATAKTINDSVVTLIERELSGVKNLLYYSATTDTSGTAEITATFKPGTDVEMAQVDVQNKIKAVEARLPQVVRQQGLQVEASSSGFLMLVGINSPNNQYSEVDLSDYLVRNVVEELKRVEGVGKVQSFGAEKAMRIWVDPNKLVSYGLSISDVNNAIRENNVEIAPGRLGDLPAEKGQLITIPLSAQGQLSSLEQFKNISLKSKTNGSVIKLSDVANVEIGSQAYNFAILENGKPATAAAIQLSPGANAVKTAEVVRAKIEELKLNLPEGMEFSIPYDTAPFVKISIEKVIHTLLEAMVLVFIVMYLFLHNVRYTLIPAIVAPIALLGTFTVMLLAGFSINVLTMFGMVLAIGIIVDDAIVVVENVERIMATEGLSPKDATSKAMKEITSPIIGITLVLAAVFLPMAFASGSVGVIYKQFTLTMSVSILFSALLALILTPALCATILKPIDGHHQKKGFFAWFDRSFDKVTKKYELMLLKIIKHTVPMMVIFLVITGITFTGMKYWPTAFMPEEDQGWFMTSFQLPSDATAERTRNVVNQFENNLKDNPDVKSNTTILGWGFSGAGQNVAVAFTTLKDFKERTSSASKMTSDVNSSMANSTEGETMAVLPPAIDELGTFSGFSLRLQDRANLGMPALLAAQDELMAMAAKNKKFYMVWNEGLPQGDNISLKIDREKLSAFGVKFSDVSDIISTSMGSMYINDFPNQGRMQQVIVQVEAKSRMQLKDILNLKVMGSSGQLVSLSEVVTPQWNKAPQQYNRYNGRPSLSIAGIPNFDTSSGEAMREMEQLIAKLPKGIGYEWTGISLQEKQSESQMAFLLGLSMLVVFLVLAALYESWAIPLSVMLVVPLGIFGAIIAIMSRGLMNDVFFKIGLITIIGLSAKNAILIVEFAKMLKEEGMSLIEATVAAAKLRLRPILMTSLAFTCGVIPLVIASGASSETQHALGTGVFGGMISATILAIFFVPVFFIFILGAVEKLFSSKKKISS	44.15	gnl|BL_ORD_ID|800|hsp_num:0	866			135	288	tigecycline; tetracycline
BGC0000787.1|O-antigen_10 # 10112 # 10633 # 1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.352	BGC0000787.1|O-antigen_10 	10112	10633	+	Loose	400	88.1965	vatE	37.12	3002844	protein homolog model	n/a	n/a	streptogramin antibiotic; streptogramin A antibiotic	antibiotic inactivation	streptogramin vat acetyltransferase	GTGTATAACAATACATTGCTTTATAATTCAAATATTGGACGTCATACTTATATTCAGAGGAATTGTACAATATTGAACACGTCAATCGGTCGGTATTGTTCTATTGCAGAAAGTGTGAAAATGGGATTAGGTAAACATCCTGTGTCGGAATATATATCGACGCATCCATTCTGTTATGGGAAAAATTCAATACATTGGCTTTCTAAAAGCTGTCCACCTCCGGATTCGCATACATTTGAAGAAACCAAAAGAATTATGATTGGTCATGATGTATGTTTGGGTGCGAATACGGTTATATTGGATGGAGTAACTGTAGGTAATGGCGCTATAATTGGGGCTGGCTCAGTTGTTACTAAGAATATACCTCCTTATGCTGTTGCTGCAGGGGTTCCTTGTAAAGTACTTTATTATCGTTTTAATGATGATACAAGAAATAAGTTGGAAAAAATGAAATGGTGGGAAAAAGATTATGAAGAACTAGAACTGATTCTTTCAGAATTTAAATATCCAGACTCGGAATAA	MYNNTLLYNSNIGRHTYIQRNCTILNTSIGRYCSIAESVKMGLGKHPVSEYISTHPFCYGKNSIHWLSKSCPPPDSHTFEETKRIMIGHDVCLGANTVILDGVTVGNGAIIGAGSVVTKNIPPYAVAAGVPCKVLYYRFNDDTRNKLEKMKWWEKDYEELELILSEFKYPDSE	MTIPDANAIYPNSAIKEVVFIKNVIKSPNIEIGDYTYYDDPVNPTDFEKHVTHHYEFLGDKLIIGKFCSIASGIEFIMNGANHVMKGISTYPFNILGGDWQQYTPELTDLPLKGDTVVGNDVWFGQNVTVLPGVKIGDGAIIGANSVVTKDVAPYTIVGGNPIQLIGPRFEPEVIQALENLAWWNKDIEWITANVPKLMQTTPTLELINSLMEK	80.84	gnl|BL_ORD_ID|1398|hsp_num:0	1519			189	567	virginiamycin M1; madumycin II; griseoviridin; dalfopristin
BGC0000787.1|O-antigen_11 # 10641 # 11807 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.278	BGC0000787.1|O-antigen_11 	10641	11807	+	Loose	600	29.6462	TLA-3	26.09	3003204	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; monobactam; cephalosporin	antibiotic inactivation	TLA beta-lactamase	ATGATGCAGATAACAATTCCAAAAAGTAATGATTTTAGACGTTTCTTTAATCCCGTTATATTAATTTTAATGTCAATCGTTTTAAACACTTTTTTTCAATTATACACCAGTGAAGAAGAATGGAATTCATTCTTTATATTTAATCAAAAACCTGATTATACGGTGTTTTTTATATCTTTAGTTTTTTATTTGTTTTTTCTTTTTGGGGCTTTTTTTGCGTATTTATTTAATTATCAAAAACATAGCAACCATAGAAGCCACTACTTATACAACTTTTCTTTTTATAATGGGTTATTAAAGTTTGTTTTTTATTCAAATGTAATAAGTTTAATTGTAACCCAGTATTACATGCACGAAGCTAATATATATAATATATATATTAGCGGTGGTGTCTCTGCTCAAACAATAGAGTCTCAGATTGCTTCATCTCCGCTGGGAATACATGGAATATCTGTAATGTTGGGCTATTTTGGTATTATTATGTATGGTATATCTCGTTTGATAAAAGATAATCGAGCTATTGTTTTTATAAGTATATTGGTTATAATAATCAAATTTATTAGTTATGCGAAATTGCAATCTTTATTATATGTTTTATTAGCTTTGATGCTATTTTCCAGACGGAGAATATCTATTAATAAAGGAGTTATAATAGGAGGTGTAGTCATTTTTTTATTTTCATTTACGCGCATAATTCGAAATCCTGAACAAAATTTATCATTGAGTTTTGATTTTTTATTTAGATTTGTTGGCGGTTTTTATTTCGGTTCACCTGTTGTTAATTTTAACTATGTTATTCAAAATAATATACAGGATGTGTTTTATTTCTTCAATTGGTTTTTACCTCAAAAAATCATTCCAGCGTCACCAATTAGCTTGGAGTTTCCAGATGTTACCTCACCTATAGGTTTTGTAGGAAGTGCTTATGTTTCATTGGGTATATTCAGCGTAATATATGCCTATTTGGTTGGGTTCATAATTCAATTAATATATTTACAGCGAAATACGTCTCCTTTTGCATTTGTTTTTCAACCATTTGTCATTATGGCCTGCATATTTGCGATGATGTATAATAATTTTGTAAATATGATATTTTTCATATTGCCGCTTATATTTTCATATTTAGTGGTTATAAAAACTATATGCGCTAGAAAGGAAGATGTTTAA	MMQITIPKSNDFRRFFNPVILILMSIVLNTFFQLYTSEEEWNSFFIFNQKPDYTVFFISLVFYLFFLFGAFFAYLFNYQKHSNHRSHYLYNFSFYNGLLKFVFYSNVISLIVTQYYMHEANIYNIYISGGVSAQTIESQIASSPLGIHGISVMLGYFGIIMYGISRLIKDNRAIVFISILVIIIKFISYAKLQSLLYVLLALMLFSRRRISINKGVIIGGVVIFLFSFTRIIRNPEQNLSLSFDFLFRFVGGFYFGSPVVNFNYVIQNNIQDVFYFFNWFLPQKIIPASPISLEFPDVTSPIGFVGSAYVSLGIFSVIYAYLVGFIIQLIYLQRNTSPFAFVFQPFVIMACIFAMMYNNFVNMIFFILPLIFSYLVVIKTICARKEDV	MKKHLIVIAFCALFASAFAAKGTDSLKNSAKGTDSLKNSIEKYLKDKKAKVGVAVLGIEDNFKLNVNEKHHYPMQSTYKFHLALAVLDKLDKENISVDKKLFVKKSDLQPNTWSPLKDKYPNGNLELSFSEIIKSTVSHSDNNGCDILFRFVGGTNKVHNFISKLGVKNISIKATEEEMHKAWNVQYTNWTTPDATVQLLKKFYKNEILSKNSYDFLLNTMIETTTGPKRLKGLLPDGTVVAHKTGSSDTNNKGITAATNDIGIITLPNGKHFAIAVYVSDSSEKSDVNEKIIAEICKSVWDYLVKDGK	125.57	gnl|BL_ORD_ID|2098|hsp_num:0	2326			117	462	
BGC0000787.1|O-antigen_12 # 11808 # 12545 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.293	BGC0000787.1|O-antigen_12 	11808	12545	+	Loose	1500	29.6462	rphB	33.33	3003992	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	ATGATTTCTGTAATTATGTGTATAAATAAATATGATTCATATGTAATGCCTGCGATAAATAGTATATTGAATCAAACTTATAAAAAATATGAGTTAATAATTGTTGCTAATGGCAATGAAGCCAGTGACATTGCCCGTGTCTTAAAAAATAACATAAAACAAACAGAGAATGTTAATATTATTGAAACCAATATAGGGCAATTGGCTTTTTCTTTAAATTTGGCAATATCCAAAGCTAAATATGATATCATCGCGAGGATGGATTCTGATGACATAGCCTTACCTAACCGACTTCAAAAGCAAATTAAATATCTTATAGATAATGAACTTGATTTAATTGGAACCTCAATAAATCTAATTGATGAAAATGATGGTTTTTTAGGTGTAAGGCTTTACCCCAGACAAAAATTAATAAATAGATATATAATGTTTCGAAACTGTTTCGCACATCCTTCAATAATGTTCAGAAAAGATTTGTTTCTTAAAACAAGAGGGTATAATGGTGGTTTTAACTCTGAAGATTATGATTTGTGGTTAAGAATGCGAAGCTTAAAACCACGTTGGGATAATATGGAAGAGCCTTTGTTAAATTACCGTGTTCACTCAAATTCAACACAGAAGTCTAAACTGGCATATTATGAATGTGCTGGGTATTCTTTGCGAGAATTTCTTAAAAAGAAAAGTATAATGAGTTTTCTTTCTTGTACATATCATTTTATTAAAGCATTAGTTAAATAA	MISVIMCINKYDSYVMPAINSILNQTYKKYELIIVANGNEASDIARVLKNNIKQTENVNIIETNIGQLAFSLNLAISKAKYDIIARMDSDDIALPNRLQKQIKYLIDNELDLIGTSINLIDENDGFLGVRLYPRQKLINRYIMFRNCFAHPSIMFRKDLFLKTRGYNGGFNSEDYDLWLRMRSLKPRWDNMEEPLLNYRVHSNSTQKSKLAYYECAGYSLREFLKKKSIMSFLSCTYHFIKALVK	MRSLVLDFQEMDKKQLGLVGGKGLHLGELSKIEGIRVPEGFCVTTIGYQRAIEQNETYQAMLNRLTMLSAEDRDQMVEISRKIRQTIMEVEIPSDVVTAVTRYLSRFGEEQAYAVRSSATAEDLPHASFAGQQDTYLNIIGVDAILQHISKCWASLFTDRAVIYRMQNGFDHRQVYLSVVVQRMVFPEASGILFTADPMTSNRKLLSIDAGFGLGEALVSGLVSADGYKVREGEIIEKRIAAKTLAIYGRKEGGTETKQIDPDQQKSQTLTDEQILQLARIGRQIEAHFGQPQDIEWCLAQDTFYIVQSRPITTLYPIPEANDQENHVYVSVGHQQMMTDPMKPLGLSFFLLTTPAPMRTAGGRLFVDTTAMLASPVSRENVLNTLGQSDPLIKDALMTILERGDFIKSLPIAENEQTPGKNNISSAGYQTPIDHDPTIVSDLMERTQSSIEVLKQNIQTKSGSDLFDFILEDIQELKKNLFDPQSSAVIMAAMNASTWINEKMNEWLGEKNAADTLSQSVPGNVTSEMGLALLDVADVIRPYPEIIDYLEQAKDDHFLDKLLTFDGGQQAQDAILDFLDKYGMRCAGEIDLTRTRWSEKPIALVPLILGNIKNFEPNASHRKFEQGRQEALKKEQELLDRLKQLPDGEGKAQETKRMIDLIRNFMGYREYPKYGMVNRYFIYKQALLKEAERLVQAGVIHHKEDIYYLTFEELDEVVRTNKLDNPGSMVEQQAKLAIRQMISKRKEEYNVFEKLTPPRVITSDGEIIAGEYKRENIPAEAIVGLPVSSGTVEGRARVILNMKDADLEEGDILVTAFTDPSWTPLFVSIKGLVTEVGGLMTHGAVIAREYGLPAVVGVENATKRIKDGQRIRVHGSEGYIEILS	27.71	gnl|BL_ORD_ID|2235|hsp_num:0	2528			1911	2052	rifampin; rifaximin; rifabutin; rifapentine
BGC0000787.1|O-antigen_14 # 13574 # 13663 # 1 # ID=1_14;partial=01;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.522	BGC0000787.1|O-antigen_14 	13574	13663	+	Loose	300	21.1718	poxtA	32.26	3004470	protein homolog model	n/a	n/a	tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGTCAAAGCAACAGATCGGCGTAGTCTGGTATGGCAGTGATGGGGCTGCAACCTTGCTGCTCAACATCGAAAGCCGTGGTTATACCGTC	MSKQQIGVVWYGSDGAATLLLNIESRGYTV	MKGKNMNLAFGLEEIYEDAEFQIGDLDKVGIVGVNGAGKTTLFRLLLGELELDNGSLTSGNARIGYLPQEIVLEDEDITVWDFLFEGRPIKKYEQELEEIYKKLETAVNAEQEALLARMGTLQERLEYFDFYEAETILLEFADKMSIDAELYHRPMRELSGGQKSKMAFARLLYSKPEILLLDEPTNHLDVSTKDFVIKYLKNYRGSVLIISHDIDFLNRIINKIMYINKATHKISVYDGDYYIYKKKYAEEQRIREMAIVQQEKEIKELSDFVQKAKQASQTNHHLKRMGQERALRLDKKRGELQKRNRLYKRVKMDIRPKREGAQVPLEVENITFHYSGYPTLYQNLSFQINGRERFLVVGENGVGKSTLLKLMMGILSPDEGCIRFNQKTDIAYYAQELEQLDENKTVIDNVESEGYTPWQIRAVLSNFLFYDDDVNKKVSVLSPGEKARVALCKILLQKANLLILDEPTNHLDPETQKIIGGNFNLFEGTIIAVSHNPSFVEQIGISRMLILPSGRIEPYSRELLEYYYEINGSVAKF	5.54	gnl|BL_ORD_ID|2510|hsp_num:0	2904			1170	1263	tetracycline; doxycycline; linezolid; chloramphenicol; florfenicol
